Invention Grant
- Patent Title: Dioxolane analogues of uridine for the treatment of cancer
-
Application No.: US16847477Application Date: 2020-04-13
-
Publication No.: US10822360B2Publication Date: 2020-11-03
- Inventor: Richard Bethell , Anders Eneroth , Bjorn Klasson , Fredrik Oberg
- Applicant: MEDIVIR AB
- Applicant Address: SE Stockholm
- Assignee: MEDIVIR AB
- Current Assignee: MEDIVIR AB
- Current Assignee Address: SE Stockholm
- Agency: Gorman IP Law, IPC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@1b013b5e com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@12f9b9a3
- Main IPC: C07D405/04
- IPC: C07D405/04 ; C07F9/6558 ; C07F9/24 ; A61K45/06 ; A61K31/675 ; A61K31/506

Abstract:
The invention provides compounds of the formula: R1 is OR11, or NR5R5′; R2 is H or F; R5 is H, C1-C6alkyl, OH, C(═O)R6, O(C═O)R6 or O(C═O)OR6; R5′ is H or C1-C6alkyl; R6 is C1-C6alkyl or C3-C7cycloalkyl; R13 is H, phenyl, pyridyl, benzyl, indolyl or naphthyl wherein the phenyl, pyridyl, benzyl, indolyl and naphthyl is optionally substituted with 1, 2 or 3 R22; and the other variables are as defined in the claims, which are of use in the treatment of cancer, and related aspects.
Public/Granted literature
- US20200239502A1 DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER Public/Granted day:2020-07-30
Information query